Asian Journal of Pharmaceutics
2007 | 6,102,844 words
The Asian Journal of Pharmaceutics (AJP), published by BRNSS Publication Hub & Mandsaur University, is an open-access, international, English-language journal issuing four editions annually since 2007. Dedicated to advancing pharmaceutical and related sciences, AJP offers a global platform for researchers to showcase their work and inspire innovati...
Fabrication, Development and Optimization of Mouth Dissolving Film of...
Sandip B. Ahire
Read the Summary
Download the PDF file of the original publication
Year: 2025 | Doi: 10.22377/ajp.v19i01.6094
Copyright (license): Creative Commons Attribution 4.0 International (CC BY 4.0) license.
[Full title: Fabrication, Development and Optimization of Mouth Dissolving Film of Ondansetron HCl by Natural Film Former]
[[[ p. 1 ]]]
[Summary: This page introduces a study on developing mouth dissolving films (MDFs) of Ondansetron HCl using natural polymers. It outlines the solvent casting method, factorial design for optimization, and promising results from batches F5, F8, F-14, F20, F24, and F25, with F25 showing rapid disintegration and drug release.]
Asian Journal of Pharmaceutic s • Jan-Mar 2025 • 19 (1) | 293 Fabrication, Development and Optimization of Mouth Dissolving Film of Ondansetron HCl by Natural Film Former Sandip B. Ahire*, Pravin B. Jadhav, Deepak B. Somavanshi, Vinod A. Bairagi Department of Pharmaceutics, K.B.H.S.S. Trust’s Institute of Pharmacy, Nashik, Maharastra, India Abstract Aim: This study aimed to develop a mouth dissolving film of Ondansetron HCl. Materials and Methods: Solvent casting method is used, and various film forming polymers such as dried cassia tora gum, konjac gum , and PVP K 30 in various concentrations were evaluated. The effect of independent factors, such as dried cassia tora gum, konjac gum , and PVP K 30 concentrations, on two dependent variables, such as disintegration time and percentage drug content, was examined using the 3 3 factorial design. The optimized formulation was identified based on a disintegration time of 5–30 s and a drug release exceeding 85%. Batches F 5, F 8, F-14, F 20, F 24, and F 25 of the formulation show promising results. Results: As a result, each of these formulation batches were considered as optimized formulations and processes for in vitro dissolution testing. Batch F 25 has a rapid disintegration time of 18.50 s and also the % drug release of 96.10% within 120 s. It contains 1% cassia tora gum, 1% konjac gum , and 1% PVP K 30. Conclusion: From the results of this study, it can be interpreted that mouth-dissolving films of Ondansetron hydrochloride are feasible to prepare, provide quick onset of action, and have improved oral bioavailability using natural polymers Keywords: Antiemetic, factorial design, Mouth dissolving film, natural film formers, solvent casting Address for correspondence: Sandip B. Ahire, K.B.H.S.S. Trust’s Institute of Pharmacy, Malegaon Dist. Nashik-423105, Maharastra, India E-mail: sandipahire 43@gmail.com Received: 04-02-2025 Revised: 23-03-2025 Accepted: 31-03-2025 INTRODUCTION T he oral route of administration is the preferred method for administering medications due to its low cost, simplicity, and high rate of patient compliance. However, the oral route seems to have some limitations such as hepatic first pass metabolism and degradation by gastrointestinal enzymes. Tablets and capsules are hard to swallow for some patients, particularly children and the elderly. Such patents are difficult to take in solid oral dosage forms [1] In the 1970 s, quick disintegrating mouth dissolving films (MDFs) were invented as a replacement to table ts and capsules for pediatric and geriatric patients. Mouth dissolving film is a new drug delivery system that was developed based on existing transdermal patch technology. Multiple approaches have been explored to deliver drug via transdermal routes to release the therapeutic agent to the particular location where it acts [2] Mouth dissolving oral films are a type of dosage form that are made with water soluble polymers that help the film hydrate more quickly in saliva, stick to the mucosal surface, and disintegrate in only a few seconds. This bypasses the hepatic first pass metabolism and increases the drug’s bioavailability [3] Vomiting is a reflex action that expels gastric contents through the mouth, often triggered by motion sickness or chemotherapy-induced nausea [3] Patients receiving chemotherapy often experience nausea and vomiting as a result of the treatment medications’ potential for an adverse reaction [4] Ondansetron hydrochloride is a potent antiemetic drug that belongs to the 5 HT 3 receptor antagonist class. It is employed to relieve nausea and vomiting caused on by chemotherapy. Ondansetron hydrochloride has been shown to significantly delay the onset of nausea in cisplatin patients [5] It is marketed in the form of standard tablets, but due to hepatic first pass metabolism, it has a poor bioavailability of 60% as well as ORIGINAL AR TICLE
[[[ p. 2 ]]]
[Summary: This page details excipient properties of Konjac gum, Cassia tora gum, and PVP K30, highlighting their uses in pharmaceutical formulations. It describes Konjac gum's solubility and gel-forming abilities, Cassia tora gum's stability, and PVP K30's role as a synthetic polymer carrier.]
Ahire, et al .: Ondansetron hydrochloride mouth dissolving film prepared from natural polymers Asian Journal of Pharmaceutic s • Jan-Mar 2025 • 19 (1) | 294 a short plasma half-life of 3–5 h, requiring repeated dosing, which could cause side effects such as headaches, constipation, or diarrhea [6] Mouth dissolving film is the best alternative dosage form for reducing dose frequency and bypassing hepatic first pass metabolism. The development of a mouthdissolving film of Ondansetron hydrochloride was the aim of this investigation. The drug reaches the systemic circulation immediately after going through hepatic first pass metabolism, which is how the MDF works. Rapid absorption from highly vascularized oral mucosa, avoidance of first pass metabolism, increased medication efficacy, and ultimately enhanced patient compliance are only a few benefits of Ondansetron hydrochloride MDF. In this research investigation, the formulation parameters were optimized using factorial design software. All three variables were examined at three levels, −1, 0 and +1, using a 3 3 factorial design. After analysis, we have 27 different combinations. Response variables included disintegration time and drug content percentage [7] The film was made using the solvent casting process, and its parameters including color, opacity, surface texture, pH of film surface, folding endurance, stiffness, rate of disintegration, percentage of drug content, and in vitro release of drugs were all examined Excipient properties Konjac gum powder Konjac (Lasioideaeamorphophallus) tubers, which are mostly farmed across Far East as well as Southeast Asia, are utilized to make konjac gum . It is a hetero-polysaccharide with both a glucose to mannose ratio of 1–3. It is made up of -D glucose and -Dmannose. As a result, it is known as a glucomannan . If heated, Konjacglucomannan dissolves quickly in an aqueous solution as well as being water-soluble under high shear Konjacglucomannan solutions become viscous as the concentration rises; they are remarkably stable in the presence of high salt concentrations but extremely sensitive to pH. Systems with lower pH have a negative impact on viscosity. Combined effects as create thermally reversible gels, konjac can cross-link with a variety of different polysaccharides, such as xanthan, carrageenan, and agar. While adding salt can prevent the production of the synergistic gel, adding sugar can increase the strength of the gel. This allows for control of the gel-forming ability In addition to controlling phase separation, imparting and controlling viscosity, improving spreadability, and extending shelf life, konjac gum provides a pleasant mouthfeel. Creates a reversible or non-thermo-non-reversible gel and, depending on the condition it has excellent water binding properties Cassia tora gumpowder The two very similar-looking seeds, Cassia tora and Obtusifolia , are widely farmed throughout India. Native Americans gather Cassia Tora/Obtusifolia seeds, which are then processed by the industry to make Cassia splits, which are then utilised to make the powder About 75% of cassia gum is made up of polysaccharides, predominantly a linear chain of 1,4-D-mannopyranose units connected by 1,6-D-galactopyranose units. About a 5:1 ratio exists between mannose and galactose Characteristics • Easy dispersion and viscosity with the increasing temperature • Exponential increase in viscosity with anincrease in concentration • Neutral Polysaccharide that is mostly not affected by the presence of other electrolytes • Good stability at a wide range of pH but unstable in a very strong acid ambient • High stability in retorted processes • Good freeze thaw stability • Interactivity with other hydro-colloids (carrageenan, xanthan gum and agar-agar). This can lead to a synergy and have a considerable effect on the consistency and elasticity with an improvement in stability when freezing/ melting and provide a better resistance to gelatinization as well PVP K 30 The pharmaceutical industry uses povidone, also known as polyvinylpyrrolidone, or PVP, as a synthetic polymer carrier for suspending and spreading medications. It can be used in many different ways, such as an adhesive for transdermal systems, a film-forming agent for ophthalmic solutions, a binder for table ts and capsules, and a flavoring agent for liquid and chewable table ts Povidone K 30, whose chemical formula is (C 6 H 9 NO)n, is a white to slightly off-white powder. Povidone formulations are widely used in the pharmaceutical sector due to their ability to dissolve in both water-based and oil-based solvents. The k number represents the molecular weight of the povidone. Povidone with greater K-values (i.e., k 90) are not typically injected due to their large molecular weights. Higher molecular weights result in the body’s accumulation and prevent renal clearance MATERIAL AND METHODS Materials Ondansetron hydrochloride drug sample was purchased from SD chemicals, Nashik, Konjacgum powder and cassia tora gum powder were purchased from Amazon online shopping
[[[ p. 3 ]]]
[Summary: This page describes pre-formulation studies including melting point determination, UV-spectrophotometry, and FTIR analysis to assess drug-excipient compatibility. It explains the solvent casting method for MDF formulation, including polymer dissolution, drug addition, drying, and cutting the film.]
Ahire, et al .: Ondansetron hydrochloride mouth dissolving film prepared from natural polymers Asian Journal of Pharmaceutic s • Jan-Mar 2025 • 19 (1) | 295 site. PVP K 30 purchased from SD chemicals, Nashik. Citric acid and other chemicals were purchased from SD chemicals, Nashik. All reagents were of analytical grade Pre-formulation studies For identification and purity of drug melting point of drug was carried out and verified with reported reference Determination of λ max of drug carried out in distilled water, pH 6.8 buffers and pH 1.2 buffers, and observed λ max was recorded Calibration curve was carried by making different concentration of drug in pH 1.2 buffer solutions and analyzed in Ultraviolet (UV)-spectrophotometer (Jasco V-730) at 266 nm The compatibility in between drug and excipient compatibility was determined using FTIR spectroscopy analysis (Jasco FT/ IR 4600) by ATR method in which drug and excipient sample directly place over ATR probe and sample were analyzed by scanning range of 500–4000 cm −1 Mouth dissolving film formulation and development The solvent casting approach has been shown to be the most reliable and advantageous method for the creation of an ondansetron hydrochloride MDF. The polymeric solution was made by measuring out how many polymers to dissolve in 20 mL of distilled water and whisking constantly until a clear liquid was formed. The drug, sweetener, and citric acid were then added in a calculated amount while this mixture was being constantly agitated on a magnetic stirrer. After that, the finished mixture was put into a Petri plate and dried in a hot air oven set at 60°C for 12 h. Subsequently, the film was meticulously extracted from the petriplate, examined for imperfections, and then chopped to the necessary dimensions (2×2 cm 2 ) The graphical process of solvent casting and prepared films are shown in Figure 1 Experimental design by full factorial The MDF for Ondansetron hydrochloride was optimized using a 3 3 factorial design (Design expert 13). Furthermore, they investigated the effect of cassia tora gum, konjac gum , and PVP K 30 concentrations on the physical and chemical test parameters of formulated MDFs. As independent variables, the amounts or concentrations of cassia tora gum factor 1, konjacgum factor 2, and PVP K 30 factor 3 were used. All three factors were tested at three different levels: −1, 0, +1, or 1%, 1.5%, and 2% w/v, respectively. Table 1 shows a 3 3 factorial design with 27 different combinations. Response variables included disintegration time and percentage drug content [7] Calculation of dose of drug in each film The dose of Ondansetron hydrochloride drug is 4 mg and in 2 cm diameter of film the quantity of drug is 4 mg. the following formula help in calculation of quantity of drug added in film Drug to be added in each film Dose of Drug per film Area of Petriplate Area of one Film = × Here, (1) Because the area of the petriplate is 9 cm 2 , the diameter is 63.64 cm 2 (2) A 2 cm film area results in a 4 cm 2 diameter (3) The quantity of drug which is to be present in 4 cm 2 of prepared film is 4 mg (4) The quantity of drug present in a 63.64 cm 2 area of petriplate is approximately 64 mg Polymeric solution is prepared Drug and excipients are added to this polymeric solution Solution is homogenized by magnetic stirrer Cast on a Petriplate Made waterless in hot air oven at 60˚C for 12 hourse Film are then attentively detached from petriplate Carve into desired shapes and sizes Figure 1: Graphical representation of solvent casting method
[[[ p. 4 ]]]
[Summary: This page presents the formulation batches with varying concentrations of Cassia tora gum, Konjac gum, and PVP K-30, along with other ingredients. It also outlines evaluation methods for the prepared films, including physical appearance, pH, weight uniformity, folding endurance, thickness, and tensile strength.]
Ahire, et al .: Ondansetron hydrochloride mouth dissolving film prepared from natural polymers Asian Journal of Pharmaceutic s • Jan-Mar 2025 • 19 (1) | 296 Table 1: Formulation batches Formulation Code Cassia tora gum (%w/v) Konjac gum (%w/v) PVP K-30 (%w/v) CitricAcid (mg) Sodium saccharin (mg) PEG 400 (mL) Drug (mg) F‑1 1 2 1.5 10 10 3 64 F‑2 1.5 2 2 10 10 3 64 F‑3 2 2 2 10 10 3 64 F‑4 2 1 1 10 10 3 64 F‑5 1 1 1.5 10 10 3 64 F‑6 1.5 1.5 2 10 10 3 64 F‑7 1.5 2 1.5 10 10 3 64 F‑8 1 1.5 1 10 10 3 64 F‑9 1 1.5 1.5 10 10 3 64 F‑10 2 1 2 10 10 3 64 F‑11 2 1.5 2 10 10 3 64 F‑12 1.5 1.5 1 10 10 3 64 F‑13 2 2 1 10 10 3 64 F‑14 1.5 1 1 10 10 3 64 F‑15 1 1.5 2 10 10 3 64 F‑16 1.5 1.5 1.5 10 10 3 64 F‑17 2 1 1.5 10 10 3 64 F‑18 1.5 2 1 10 10 3 64 F‑19 1.5 1 2 10 10 3 64 F‑20 1 2 1 10 10 3 64 F‑21 2 1.5 1.5 10 10 3 64 F‑22 1 2 2 10 10 3 64 F‑23 2 1.5 1 10 10 3 64 F‑24 1 1 2 10 10 3 64 F‑25 1 1 1 10 10 3 64 F‑26 1.5 1 1.5 10 10 3 64 F‑27 2 2 1.5 10 10 3 64 Evaluation of ondansetrin hydrochloride prepared mouth dissolving films Physical appearance test Physical evaluation visually done for uniformity of color, transparency and texture of film surface [8] pH of film surface It was determined by digital pH meter by dissolving the film into 5 mL of phosphate buffer (pH 6.8 buffer) Uniformity of weight of films It was calculated by weighing each film individually, adding them all together, and then computed the average weight of the film. n = 3 Folding endurance This was done by doing the number of folds of film until it get broken down or formation of visible creaks it helps to evaluate brittleness of the film. Value of folding endurance recorded as how many times of folds essential to break the film [9] Determination of thickness of film This was determined by measuring the individual film thickness by calibrated vernier caliper, all measurement done for 3 times [10] Determination of tensile strength It can be defined as the point atfilm get breaks relative to the highest stress applied. In order to conduct this test, films were sandwiched between two paper clips, one of which was attached to the clamp of burette stand and the other to the weighing balance. By dropping the weight into the weighing pan, the film is tugged until it breaks. Applying the load at rupture divided by the cross sectional area of the film yields the tensile strength. n = 3.
[[[ p. 5 ]]]
[Summary: This page continues outlining the evaluation methods for the films, including disintegration time, drug content, and drug release determination using USP type II apparatus. It also mentions FTIR analysis to check for drug-excipient interactions and DSC thermal analysis to analyze thermal stability.]
Ahire, et al .: Ondansetron hydrochloride mouth dissolving film prepared from natural polymers Asian Journal of Pharmaceutic s • Jan-Mar 2025 • 19 (1) | 297 ( ) 100 Tensile strenght Load at failure weight in grams pan weight Stripthickness strip width = + × × Determination of time required for disintegration of film In order to conduct this test, a petriplate containing 25 mL of pH 6.8 phosphate buffer was used. The time at which the film began to break was noted and recorded. Three times the test was repeated Determination of % drug content The individual film used in this test had 4 mg of Ondansetron hydrochloride equivalent weight. It was dispersed in 100 mL of distilled water and shaken for approximately 10 mines before being filtered through a 0.45 m membrane filter. After that, a UV spectrophotometer was used to evaluate 1 mL of the sample at 310 nm after diluting it with 10 mL of distilled water (Jasco V 730). Three times of each test were conducted [11] following that, the drug content was calculated using the formula below: % 100 Practical yield drug content Theorotical yeild = × Determination of % drug release The USP type II paddle apparatus was employed for this test, which was conducted at a temperature of 37 ± 0.5°C with phosphate buffer at pH 6.8 serving as the dissolution media. The samples were taken out at regular intervals of 0 s, 10 s, 20 s, 30 s, and 40 s to last 120 s, with the same quantity of new dissolution media being replaced to keep the sink condition. After then, absorbance was calculated at 310 nm with a UV-Visible spectrophotometer [12] FTIR of formulation ATR technique was used to take FTIR spectra of mouthdissolving film, and the spectra were run between 400 and 500 cm −1 . It was noted that there was no evidence of a drug-excipient interaction. Prior to the preparation of film, compatibility investigations of the pure drug ondansetronHCl with polymers were conducted. Fig ures 2 -5 depict the IR spectra of the drug ondansetronHCl in both its pure and with polymers. The presence of all of ondansetronHCl distinctive peaks in the spectra suggests that the drugs are compatible with used polymers of films. It demonstrates that the there was no interaction found DSC thermal analysis To analyze the complex formation and thermal stability of the medication in its formulation, DSC thermal analysis was performed. Research was conducted with Japan, Shimadzu, TA 60 software, and DSC 60. The sample was weighed precisely, put on an aluminum plate, covered with an aluminum lid, and heated steadily at a rate of 5°C/min per minute between 0 and 250°C Stability study The optimized formulation batch F 25 were stored with proper packaging in environmental stability chamber for 1-3 months. The disintegration and dissolution tests were carried out to know any variation RESULT AND DISCUSSION The objective was to produce a film that would dissolve in the mouth for Ondansetron hydrochloride. To optimize Figure 2: FTIR spectra of pure drug ondansetron hydrochloride
[[[ p. 6 ]]]
[Summary: This page discusses the results and discussion of the study. It includes FTIR spectra of pure drug ondansetron hydrochloride, aiming to produce a mouth dissolving film. It also covers pre-formulation studies and melting point determination.]
Ahire, et al .: Ondansetron hydrochloride mouth dissolving film prepared from natural polymers Asian Journal of Pharmaceutic s • Jan-Mar 2025 • 19 (1) | 298 Figure 5: FTIR spectra of PVP K 30 the factorial design, Design Expert 13 software was utilized. Solvent casting was used to successfully create Ondansetron hydrochloride MDFs, and the outcomes were evaluated Figure 3: FTIR spectra of Cassia tora gum powder Figure 4: FTIR spectra of Konjac gum powder
[[[ p. 7 ]]]
[Summary: This page continues with pre-formulation studies, detailing λ max determination, calibration curve creation, and FTIR analysis of drug and excipients. It presents FTIR spectra interpretations and DSC thermal analysis results, along with physical properties of the films.]
Ahire, et al .: Ondansetron hydrochloride mouth dissolving film prepared from natural polymers Asian Journal of Pharmaceutic s • Jan-Mar 2025 • 19 (1) | 299 Pre-formulation studies For identification and purity of drug melting point of drug was carried out by capillary method in microcontroller based melting point apparatus and it was found to be 231–232°C which compiles with reference For λ max determination, the 100 ppm stock solution was prepared by taking 10 mg Ondansetron hydrochloride in distilled water, pH 6.8 buffer and pH 1.2 buffer, respectively, and UV spectra of 10 µ g/mLof Ondansetron hydrochloride in 1.2 pH buffer was taken in the range of 200–400 nm and λ max was recorded it was found to be 266 nm as shown in Figure 6 Calibration curve was carried by making 10 ppm, 20 ppm, 30 ppm, 40 ppm, 50 ppm concentration of drug in pH 1.2 buffer solution and analyzed in UV-spectrophotometer (Jasco V-730) at 266 nm was liner and R 2 was found to be 0.9997 as shown in Figure 7 The compatibility in between drug and excipient compatibility was determined using FTIR spectroscopy analysis by ATR method. Small quality of ondansetron hydrochloride was placed over ATR probe prism and IR spectra wererun from 4000 to 500 cm −1 IR spectra is shown in Fig ure 2 and interpreted in Table 2 . Small quality of Cassia tora gum powder was placed over ATR probe prism and IR spectra were run from 4000 to 500 cm −1 IR spectra is shown in Figure 3 and interpreted in Table 3. Small quality of Konjac gum powder was placed over ATR probe prism and IR spectra were run from 4000 to 500 cm −1 IR spectra is shown in Figure 4 and interpreted in Table 4. Small quality of PVP K 30 powder was placed over ATR probe prism and IR spectra were run from 4000 to 500 cm −1 IR spectra is shown in Fig ure 5 Pure PVP K 30’s FTIR spectra (Figure 2) revealed a distinctive absorption band at 1658 cm −1 . The carbonyl group is to blame for this. The hygroscopic character of PVP K 30 is revealed by the extremely broad band at 3440 cm −1 , which indicates the presence of moisture DSC thermal analysis The thermal behavior of ondansetron hydrochloride shows crystallinity of ondansetron hydrochloride sharp endothermic peak observed at 221–222°C (Figure 8) Determination of physical properties All of the films were tested for color, transparency, and surface texture for visual appeal (Table 5 ). Conclusion: Formulated films were found to have a smooth texture, be transparent, and be free of air bubbles Figure 6: UV‑Spectra of ondansetron hydrochloride Figure 8: DSC thermogram of ondansetron hydrochloride Figure 7: Calibration curve of ondansetron hydrochloride Determination of pH of film surface The surface pH of formed films is displayed in Table 5. The film’s surface pH was found to be between 6.45 ± 0.01 and 6.98 ± 0.06, suggesting that it is nearly neutral and that the MDF does not irritate the oral cavity’s mucosal membranes Determination of uniformity of weight The observations are reported in Table 5, and it was found that all films shows uniformity of weight between 99.00 ±
[[[ p. 8 ]]]
[Summary: This page presents results for film folding endurance, thickness, tensile strength, and uses experimental design to analyze formulation batches. It discusses the influence of variables on disintegration time, using a quadratic model and equations to represent the relationships.]
Ahire, et al .: Ondansetron hydrochloride mouth dissolving film prepared from natural polymers Asian Journal of Pharmaceutic s • Jan-Mar 2025 • 19 (1) | 300 1.10 mg and 213.00 ± 0.70 mg. form results it was concluded that comparative gain in the weight of film was saw with increase in thickness of film Determination of film folding endurance In accordance with the folding endurance data shown in Table 5, it was observed that all films had a folding endurance of more than 300 folds, proving that all formulations had adequate film-forming properties Determination of film thickness Table 5 reports the findings of the film thickness measurement, which was made using a vernier calliper and found to be between 0.084 ± 0.32 mm and 0.305 ± 0.21 mm. Conclusion: As the concentration of the polymers increased, a proportionate increase in the film’s thickness was observed. This might be as a consequence of the formation of a sufficient hydrogen connection between the plasticizer and the polymer, which gives the polymer flexibility to withstand fracture Determination of film tensile strength The tensile strength results are shown in Table 5. According to the results, the tensile strength of the film falls as polymer concentration rises. The measured values imply that the ondansetron hydrochloride film’s mechanical stress was adequate to withstand the stress during shipping Experimental design full factorial for formulation batches Using design expert 13 software, the influence of independent variables on response was examined. Table 6 displays the formulation batches screen and 27 potential combinations generated by the software. Several models, including linear, 2 FI, quadratic, and cubic, were fitted to the data; the best model was then recommended by software and tested using an analysis of variance. Also, regression polynomials were computed for each of the independent variables, after which each dependent variable’s response (R) was used to generate a contour plot and a 3 D surface graph , which were then stated as equations 1 and 2. The primary effects A, B, and C represent the average results of moving from low to high concentration by changing one factor at a time. To investigate nonlinearity, the polynomial terms B 2 were included The effect of formulation variables on in vitro disintegration time The prepared films’ saw disintegration times ranged from 18.51 to 66.45 seconds, based on the film disintegration test findings displayed in Table 6. The fastest disintegration time is shown by the film F-27 formulation, which has the greatest concentrations of Cassia tora gum (2% w/v), Konja gum (2% w/v), and medium amounts of PVP K 30 (1.5% w/v). The batch with the slowest rate of disintegration is batch F-25. After factorial design was employed, the program suggested a quadratic model, which was found to be significant with a model F = 9.45, P = 0.0003, and R 2 = 0.5510 respectively. Any model term that has a P < 0.05 is deemed significant The following is the model response Y 1 Disintegration time: Y 1 = +36.85+6.94 A+6.12 B+3.02 C Equation 1 The concentrations of A ( Cassia toragum mucilage powder), B ( Konjacglucoman mucilagepowder ), and C (PVP K 30 concentration) have a beneficial impact on the disintegration time, according to equation 1. This implies that the rate of film disintegration is precisely proportional Table 2: Interpretation of FTIR of ondansetron hydrochloride IR frequencies cm −1 Functional groups 758 cm −1 Ortho‑ disubstituted benzene ring 1280 cm −1 Cyano group vibration(‑CN) 1459 cm −1 Methyl group(‑CH 3) 1531 cm −1 Aromatic ring double bond(‑C=C‑) 1638 cm −1 Cyano and keto group in 6 membered ring (‑C=O,‑CN) 3487 cm −1 Hydroxyl group (‑OH) 3410 cm −1 Table 3: Interpretation of FTIR spectra of Cassia tora gum powder IR frequencies cm −1 Functional groups 4813 and 875 cm −1 Anomeric configurations ( {?} and {?} conformers) and glycosidic linkages 1198 and 983 cm −1 Stretching vibration of C–O in C–O–H bonds 1149 cm −1 Bending vibrational modes of C–O, present in the pyranose ring 1134 and 983 cm −1 C–OH bending 2800–3000 cm −1 C–H stretching 3100–3500 cm −1 O–H stretching vibration Table 4: Interpretation of FTIR spectra of Konjac gum powder IR frequencies cm −1 Functional groups 3400.23 cm −1 O–H stretch 2927.43 cm −1 C–H stretch 1609.79 cm −1 C=O stretch 1175.4 cm −1 bridge O stretch 1080.15 cm −1 C–O stretch
[[[ p. 9 ]]]
[Summary: This page presents physical observations of the films, including color, transparency, texture, pH, folding endurance, weight, thickness and tensile strength. It also includes a table summarizing the physical properties of different formulations.]
Ahire, et al .: Ondansetron hydrochloride mouth dissolving film prepared from natural polymers Asian Journal of Pharmaceutic s • Jan-Mar 2025 • 19 (1) | 301 Table 5: Physical observation of films Formulation code Color of film Transparency of film Surface texture pH of surface of film Film folding endurance Film weight (mg) Film thickness (mm) Film tensile strength (Kg/mm 2 ) F 1 Milky white Translucent Soft & Smooth 6.20±0.02 ˃ 300 174±0.98 0.149±0.12 0.521±1.12 F 2 Milky white Translucent Soft & Smooth 6.45±0.04 ˃ 300 181±1.01 0.203±0.01 0.605±0.80 F 3 Milky white Translucent Soft & Smooth 6.56±0.06 ˃ 300 173±1.04 0.205±0.25 0.755±0.15 F 4 Milky white Translucent Soft & Smooth 6.81±0.05 ˃ 300 172±1.05 0.188±0.11 0.640±0.11 F 5 Milky white Translucent Soft & Smooth 6.62±0.07 ˃ 300 145±1.14 0.084±0.32 1.011±0.14 F 6 Milky white Translucent Soft & Smooth 6.67±0.03 ˃ 300 165±1.04 0.208±0.15 0.520±0.12 F 7 Milky white Translucent Soft & Smooth 6.44±0.01 ˃ 300 180±1.07 0.186±0.07 0.466±0.15 F 8 Milky white Translucent Soft & Smooth 6.38±0.05 ˃ 300 126±1.15 0.173±0.05 0.550±0.08 F 9 Milky white Translucent Soft & Smooth 6.70±0.08 ˃ 300 134±1.17 0.174±0.18 0.651±0.09 F 10 Milky white Translucent Soft & Smooth 6.72±0.07 ˃ 300 149±1.14 0.202±0.16 0.480±0.11 F 11 Milky white Translucent Soft & Smooth 6.81±0.09 ˃ 300 175±1.04 0.251±0.21 0.788±0.14 F 12 Milky white Translucent Soft & Smooth 6.85±0.05 ˃ 300 165±0.98 0.214±0.15 0.611±0.15 F 13 Milky white Translucent Soft & Smooth 6.69±0.03 ˃ 300 179±0.87 0.255±0.08 0.619±0.45 F 14 Milky white Translucent Soft & Smooth 6.75±0.04 ˃ 300 168±0.64 0.171±0.01 0.514±0.31 F 15 Milky white Translucent Soft & Smooth 6.98±0.06 ˃ 300 144±0.45 0.201±0.09 0.490±0.19 F 16 Milky white Translucent Soft & Smooth 6.85±0.07 ˃ 300 162±1.02 0.182±0.12 0.718±0.02 F 17 Milky white Translucent Soft & Smooth 6.63±0.08 ˃ 300 213±0.78 0.214±0.15 0.861±0.08 F 18 Milky white Translucent Soft & Smooth 6.48±0.02 ˃ 300 198±0.17 0.231±0.23 0.770±0.15 F 19 Milky white Translucent Soft & Smooth 6.51±0.01 ˃ 300 145±1.36 0.148±0.17 0.901±0.13 F 20 Milky white Translucent Soft & Smooth 6.74±0.07 ˃ 300 170±1.11 0.153±0.11 1.011±0.18 F 21 Milky white Translucent Soft & Smooth 6.73±0.02 ˃ 300 184±0.95 0.211±0.15 0.762±0.08 F 22 Milky white Translucent Soft & Smooth 6.45±0.01 ˃ 300 201±1.01 0.312±0.12 0.612±1.02 F 23 Milky white Translucent Soft & Smooth 6.46±0.03 ˃ 300 178±1.07 0.218±0.05 0.461±1.08 F 24 Milky white Translucent Soft & Smooth 6.76±0.05 ˃ 300 165±1.05 0.098±0.15 0.754±1.06 ( Contd ...)
[[[ p. 10 ]]]
[Summary: This page continues Table 5 and discusses the effect of formulation variables on disintegration time. It also presents Table 6 with formulation batches, factors, and responses, and describes the impact of polymer content on disintegration time.]
Ahire, et al .: Ondansetron hydrochloride mouth dissolving film prepared from natural polymers Asian Journal of Pharmaceutic s • Jan-Mar 2025 • 19 (1) | 302 Table 5: ( Continued ) Formulation code Color of film Transparency of film Surface texture pH of surface of film Film folding endurance Film weight (mg) Film thickness (mm) Film tensile strength (Kg/mm 2) F 25 Milky white Translucent Soft & Smooth 6.78±0.07 ˃ 300 99±1.10 0.096±0.18 1.08±1.02 F 26 Milky white Translucent Soft & Smooth 6.68±0.09 ˃ 300 114±1.05 0.151±0.11 0.822±1.07 F 27 Milky white Translucent Soft & Smooth 6.58±0.09 ˃ 300 113±1.02 0.142±0.13 0.832±1.17 Table 6: Formulation of batches of mouth dissolving film of on dansetron hydrochloride as per experimental design Run Formulation code Factor 1 A: Cassia tora gum (% w/v) Factor 2 B: Konjac glucomman mucilage powder (%w/v) Factor 3 C: PVPK 30 (%w/v) Response 1 disintegration time (second) Response 2 drug content (%) 1 F‑1 1 2 1.5 36.13±0.21 67.17±0.11 2 F‑2 1.5 2 2 47.16±0.52 63.83±0.45 3 F‑3 2 2 2 36±0.01 82±0.48 4 F‑4 2 1 1 42±0.26 68.47±0.14 5 F‑5 1 1 1.5 26.61±0.74 94.85±0.33 6 F‑6 1.5 1.5 2 47±0.12 62±0.15 7 F‑7 1.5 2 1.5 35.11±0.14 72.5±0.47 8 F‑8 1 1.5 1 23±0.21 90.77±0.05 9 F‑9 1 1.5 1.5 37.36±0.14 65.27±0.78 10 F‑10 2 1 2 42±0.87 69.61±0.98 11 F‑11 2 1.5 2 63±0.15 68.63±0.45 12 F‑12 1.5 1.5 1 36.33±0.64 67±0.61 13 F‑13 2 2 1 54.33±0.11 53.55±0.07 14 F‑14 1.5 1 1 26.33±0.47 89.18±0.12 15 F‑15 1 1.5 2 33.66±0.18 64.51±0.47 16 F‑16 1.5 1.5 1.5 39.33±0.14 74±0.77 17 F‑17 2 1 1.5 36.31±0.07 71.43±0.12 18 F‑18 1.5 2 1 40.23±0.46 72.63±0.85 19 F‑19 1.5 1 2 26.35±0.14 88.73±0.44 20 F‑20 1 2 1 25.46±0.34 84.54±0.66 21 F‑21 2 1.5 1.5 38.23±0.32 85.13±0.47 22 F‑22 1 2 2 46.53±0.07 66.47±0.33 23 F‑23 2 1.5 1 52±0.84 72.54±0.44 24 F‑24 1 1 2 24.63±0.46 91.13±0.78 25 F‑25 1 1 1 18.51±0.05 96.83±0.41 26 F‑26 1.5 1 1.5 30±0.77 81.97±0.60 27 F‑27 2 2 1.5 66.45±0.03 65.47±0.07 to the increase in A, B, and C concentration. Ondensetron hydrochloride film disintegration time was discovered to be influenced by polymer content. The relative impact factor was determined using the coding equation by comparing the factor coefficients. With the aid of a contour map, the combined impacts of factor A, B, and C were further understood. The effects of the concentrations of A, B, and C on the disintegration time of the ondansetron hydrochloride film are shown in Figures 9 and 10, 2 & 3 D response surface plots.
[[[ p. 11 ]]]
[Summary: This page discusses the effect of formulation variables on drug content, noting the quadratic model used for analysis. It explains the impact of factors A, B, and C on drug content, and presents findings on formulation optimization and in vitro dissolution studies.]
Ahire, et al .: Ondansetron hydrochloride mouth dissolving film prepared from natural polymers Asian Journal of Pharmaceutic s • Jan-Mar 2025 • 19 (1) | 303 Effect of formulation variables on % drug content Table 6 presents the findings. The drug content of formed film was discovered to be between 53.55 ± 0.07% and 96.83 ± 0.41%. The formulations with the highest drug content are F-5, F-24, and F-25. When factorial design was used, the software proposed a quadratic model, which was found to have an F = 6.91, a P = 0.0008, and an R 2 = 0.5951—signifying that the model was significant. Every model term is significant if the P < 0.05. Below is the model response R 2 (% drug content): Y 2 = +70.40−3.51 A−7.11 B−3.23 C+7.37 B 2 Equation 2 The (−) sign of factors A, B, and C has a negative impact on drug content, while factors B 2’s (+) sign indicates a positive impact. This was concluded from Equation 2. With the help of a contour plot, the combined impacts of factor A, B, and C were further understood. 3 D response surface plots in Figure 11 that the impact of A, B, and C concentrations on the percentage of drugs in films is depicted in Figure 12 . Ondansetron hydrochloride film drug content was found to be directly correlated with polymer concentration. The percentage of drugs in the film reduces as polymer concentration rises. The drug content in batches F-5, F-24, and F-25 is above 90% Formulation optimization by 3 3 factorial deign Two response variables, Y 1 and Y 2, were taken into consideration to enhance the formulation process. Conclusion: If the mouth-dispersing film’s disintegration time is long, there may be a chance that it would not provide immediate relief from the symptoms for which it is prescribed, and if its drug concentration is low, the film will release less medication into the bloodstream to have the desired effect. This leads to the conclusion that the formulations with a disintegration time between 10 and 30 seconds and a desired drug content of at least 85% were to be chosen as optimal formulations. Batches F-5, F-8, F-14, F-20, F-24, and F-25 of the formulation all exhibit all the predicted characteristics; therefore, all of the formulations were deemed to be optimized formulations and were processed further for an in vitro dissolution study to determine the release in phosphate buffer pH 6.8 In vitro dissolution study of optimized mouth dissolving film It was calculated that the maximum drug release at 120 s would be 96.10 ± 0.82% and the minimum drug release would be 83.21 ± 0.05%. The results are listed in Table 7 and the release pattern is depicted in Figure 13. This test was conducted for all optimized film formulations in a phosphate buffer pH 6.8 at 50 rpm. The best batch of formulas among all optimized batches was determined to be F-25. This improved batch includes PVP K 30 (1%), Konjacgum (1%), and Cassia tora gum (1%). The optimized batch F-25 demonstrates faster drug release (96.10 ± 0.82%) and a shorter disintegration time (18.51 ± 0.05 s) in within 120 s Figure 9: Two diamentional 2 D counter plot response Y 1 disintegration time Figure 11: Two diamentional 2 D counter plot for response Y 2% drug content Figure 10: Three diamentional 3 D response surface plot for response Y 1 disintegration time
[[[ p. 12 ]]]
[Summary: This page presents FTIR results for the optimized formulation, DSC thermal analysis, and stability study data. It includes dissolution profiles and FTIR spectra, concluding that the prepared films are stable and there were no interactions between drug and excipients.]
Ahire, et al .: Ondansetron hydrochloride mouth dissolving film prepared from natural polymers Asian Journal of Pharmaceutic s • Jan-Mar 2025 • 19 (1) | 304 Figure 12: Three dimensional 3 D response surface plots for response Y 2% drug content FTIR of formulation In the IR spectra of formulation all peaks of drug and excipients observed with slight shift of frequencies. Hence from Fig ure 14 it concludes there were no interaction between drug and excipients DSC thermal analysis DSC 60, with TA 60 software, Shimadzu, Japan, were used in the studies. Precisely weighed samples were put on an aluminum plate, covered with an aluminum lid, and heated steadily at a rate of 5°C/min across the temperature range of 0–250°C (Figures 8 and 15) From DSC thermogram, it was concluded that the formulation batch F 25 shows melting point of ondansetron hydrochloride at 213°C–240°C with shorter endothermic peak it may happen because of effect of film former on physical properties of drug. It suggests that there were no interaction or degradation of ondansetron hydrochloride in film formulation Stability study The optimized formulation batch F 25 were stored with proper packaging in environmental stability chamber for 1-3 months and the disintegration time and dissolution study were carried out it was observed that there was no any major variation observed when compared with previous results of same batch F 25. It suggests that prepared films of ondansetron hydrochloride are s table Table 7: Dissolution study data Time Sec. F 5 F 8 F 14 F 20 F 24 F 25 10 0 0 0 0 0 0 20 56 55 54 52 59 70 30 65 61 56 55 64 72 40 70 66 60 59 69 74 50 72 70 63 62 72 79 60 74 72 66 68 76 80 70 76 75 70 73 79 84 80 77 78 73 75 82 86 90 80 81 77 77 86 88 100 84 85 81 79 89 90 110 88 89 85 82 90 92 120 91 90 88 84 92 96 Figure 13: Dissolution profiles of optimized batches Figure 14: FTIR of formulation optimize batch F 25
[[[ p. 13 ]]]
[Summary: This page concludes that mouth-dispersing films of Ondansetron hydrochloride are feasible, provide quick action, and improved bioavailability. It acknowledges contributors and funding, and lists references used in the study.]
Ahire, et al .: Ondansetron hydrochloride mouth dissolving film prepared from natural polymers Asian Journal of Pharmaceutic s • Jan-Mar 2025 • 19 (1) | 305 CONCLUSION One of the patient-friendly dose forms for symptoms when a quick onset of the drug’s effects is necessary, the MDF is the dosage form which full-fill this need. Based on the findings, it can be said that the solvent casting approach is an easy and repea table method for producing an ondansetron hydrochloride mouth film. According to experimental findings, altering the polymer concentration may have an impact on the dissolution rate and drug content of films. In a formulation with a 1% concentration of Cassia tora gum, 1% Konjac gum , and PVP K 30, the drug is released quickly within 120 s with (96.10 ± 0.82%) drug release. From the results of this study, it can be interpreted that mouthdispersing films of Ondansetron hydrochloride are feasible to prepare, provide quick onset of action, have improved oral bioavailability, increase patient compliance, and have higher therapeutic efficacy when compared to other traditional oral dosage forms AKNOWLEDMGMENT All authors are thankful to K.B.H.S.S. Trust’s Institute of Pharmacy, Malegaon Dist. Nashik (Maharashtra) India for providing facility for research work. Also thankful to IQAC cell of Savitribai Phule Pune University, Pune Maharashtra (India), for providing funding under ASPIRE minor research project grant for year 2019–2021 FUNDING INFORMATION This research work financially assisted by IQAC cell of Savitribai Phule Pune University, Pune under ASPIRE minor research project grant for year 2019–2021 Figure 15: DSC Thermogram of formulation batch F 25 of mouth dissolving film CONFLICTS OF INTEREST None REFERENCES 1. Mahboob MB, Riaz T, Jamshaid M, Bashir I, Zulfiqar S. Oral films: A comprehensive review. Int Curr Pharm J 2016;5:111-7 2. Maheswari KM, Devineni PK, Deekonda S, Shaik S, Uppala NP, Nalluri BN. Development and evaluation of mouth dissolving films of amlodipine besylate for enhanced therapeutic efficacy. J pharm (Cairo) 2014;2014:520949 3. Kalia V, Garg T, Rath G, Goyal AK. Development and evaluation of a sublingual film of the antiemetic granisetron hydrochloride. Artif Cells Nanomed Biotechnol 2014;44:842-6 4. Nishimura M, Matsuura K, Tsukioka T, Yamashita H, Inagaki N, Sugiyama T, et al. In vitro and in vivo characteristics of prochlorperazine oral disintegrating film. Int J Pharm 2009;368:98-102 5. Kumaria R, Gupta V, Bansal S, Wadhwa J, Nair AB. Oral buccoadhesive films of ondansetron: Development and evaluation. Int J Pharm Investing 2013;3:112-118 6. Pawar HA, Kamat SR. Development and evaluation of mouth dissolving film of ondansetron hydrochloride using HPMC E 5 in combination with taro gum and other commercially available gums. J Mol Pharm Org Process Res 2017;5:138 7. Shiledar RR, Tagalpallewar A, Kokare CR. Formulation and in vitro evaluation of xanthan gum-based bilayered mucoadhesive buccal patches of zolmitriptan. Carbohydr Polym 2014;101:1234-42 8. Pathan A, Gupta MK, Jain NK, Dubey A, Agrawal A. Formulation and evaluation of fast dissolving oral film of promethazine hydrochloride using different surfactant. J Innov Pharm Biol Sci 2016;3:74-84 9. Deepthi PR, Kumar KS. Formulation and evaluation of amlodipine besylate oral thin films. Int J Pharm Sci Res 2016;7:199-205 10. Bonsu MA, Kwakye KO, Kipo SL, Boakye-Gyasi ME, Fosu MA. Development of oral dissolvable films of diclofenac sodium for osteoarthritis using Albizia and Khaya gums as hydrophilic film formers. J Drug Deliv 2016;2016:6459280 11. Koland M, Sandeep VP, Charyulu NR. Fast dissolving sublingual films of ondansetron hydrochloride: Effect of additives on in vitro drug release and mucosal permeation. J Young Pharm 2010;2:216-21 12. Chougule PC, Bhat MR, Chimkode RM. Design and evaluation of formulated mouth dissolving film of domperidone and study the effect of concentration of polymers on drug release. Asian J Pharm 2017;11:1-10 Source of Support: Nil. Conflicts of Interest: None declared.
Other Health Sciences Concepts:
Discover the significance of concepts within the article: ‘Fabrication, Development and Optimization of Mouth Dissolving Film of...’. Further sources in the context of Health Sciences might help you critically compare this page with similair documents:
Cassia tora, Immediate relief, Therapeutic agent, Physical properties, Original article, Experimental design, Negative impact, Therapeutic efficacy, Drug delivery system, Positive impact, Stability study, Dosage form, Oral mucosa, Oral route, Analytical grade, Hydroxyl group, Disintegration time, Oral route of administration, Conflicts of interest, Oral bioavailability, Melting point, Systemic circulation, Distilled water, Uniformity of weight, Citric Acid, Calibration curve, Dissolution rate, Patient compliance, Tensile strength, FTIR, Vernier caliper, Solvent casting method, Drug-excipient interaction, In-vitro disintegration time, Folding endurance, In Vitro Dissolution Study, IR Spectra, Optimized formulation, PVP K 30, Synergy, Formulation Optimization, UV Spectrophotometer, Buffer Solution, Dissolution profile, Pre-formulation studies, Drug content, Dissolution study, Drug-excipient compatibility, Povidone, Factorial design, Drug release, Stock Solution, Phosphate buffer pH 6.8, In vitro dissolution testing, Ondansetron hydrochloride, Response surface plot, Hepatic first-pass metabolism, UV spectra, Magnetic stirrer, Capillary method, FTIR spectra, Film thickness, Oral thin film, PEG 400, Solvent casting, Optimal formulation, Optimized batch, Chemotherapy-induced nausea, DSC thermogram, Film forming polymer, Natural polymer, Ondansetron HCL, Polymer concentration, Motion sickness, Poor bioavailability, Carbonyl group, Fast dissolving oral film, Antiemetic, Functional group, Sublingual film, Percentage drug content, Hot air oven, Mouth dissolving film, Digital pH meter, Quick onset of action, Polyvinylpyrrolidone, Quadratic Model, Water-soluble polymer, FTIR spectroscopy analysis, Plasma half life, Medication Efficacy, Sodium saccharin, Polymeric solution, Oral film, Drug Content Percentage, Drug dose, Film Forming Agent, Dose of Drug, Dependent variable, Independent variable, Rapid disintegration time, Drug sample, Polymer content, Faster drug release, Film parameters, Formulation parameter, Contour plot, Drug and excipient compatibility, Formulation variable, Petri plate, Vascularized oral mucosa, Melting point of drug, Minor Research Project, High shear, Sharp endothermic peak, Independent factor, Funding information, Response variable, 5-HT 3 receptor antagonist, Factor coefficients, Aluminum plate, Model term, MDF, Glucomannan, Antiemetic drug, Tensile strength results, Factor A, Factor B, Factor C, Contour map, Design Expert 13 software, Model response.
